It has been found that TRIM44 is overexpressed in a variety of tumors and is involved in malignant tumor progression, including colorectal cancer [31], esophageal cancer [32], renal cell carcinoma [33], and breast cancer [34]. This evidence concerns the gene TRIM44 and renal cell carcinoma.